Skip to Content

54 346 (Lithium Carbonate Extended Release 450 mg)

Pill with imprint 54 346 is White, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; mania; schizoaffective disorder; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 346

Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346  Front
Lithium carbonate extended release 450 mg 54 346  Back
Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346

Lithium Carbonate Extended Release

Imprint:
54 346
Strength:
450 mg
Color:
White
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roxane Laboratories, Inc.
Inactive Ingredients:
ferrosoferric oxide
magnesium stearate
povidone
sodium alginate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0655 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide